Antigen presentation by MHCII in cross-presenting dendritic cells. – Help2Kill
The activation of long-lived cytotoxic CD8+ T cell responses is central to protective immunity against viruses and tumours. This type of immune response is activated by antigenic presentation on MHCI at the surface of type 1 DCs (DC1s) after the phagocytosis of dead cells carrying antigen. This process is termed as cross-presentation. Efficient activation of CD8+ T cells also requires antigenic presentation by MHCII to CD4+ T cells. Genetic evidences and intra-vital imaging studies support the notion that the same cross-presenting DCs also perform MHCII presentation. Therefore, the coordination of both MHCI and MHCII presentation is crucial for immune responses but remains ill ill-understood.
Specifically, we intend:
1. To assess simultaneously the dynamics of MHCII and MHCI trafficking and presentation/cross-presentation in phagocytic DC1s.
2. To identify key DC1-associated genes encoding for traffic regulators supporting MHCII presentation.
3. To assess the contribution of DC1-associated MHCII regulators in the induction of long-lived CD8+ T cells responses in vivo using DC1-specific gene targeting.
Project coordination
Pierre GUERMONPREZ (Centre de recherche sur l'inflammation)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
INSERM
CRI Centre de recherche sur l'inflammation
Help of the ANR 494,526 euros
Beginning and duration of the scientific project:
September 2017
- 48 Months